Bovine genital campylobacteriosis (vibriosis): vaccination of experimentally infected bulls.
The therapeutic efficacy of a Campylobacter fetus subsp venerealis bacterin was determined in experimentally infected bulls. Ten of twelve 5-year-old Angus bulls became infected after being infused intrapreputially with C fetus subsp venerealis. Of the 10 bulls, 6 were vaccinated with 5 ml of C fetus subsp venerealis vaccine on 2 occasions 4 weeks apart. Preputial washings of the vaccinated bulls were culturally negative by the 8th week after primary vaccination. None of the 18 heifers exposed to the vaccinated bulls became infected. The 4 infected, nonvaccinated bulls remained culturally positive to C fetus (P less than 0.002), and each bull infected at least 1 heifer (P less than 0.001). Two noninfected, nonvaccinated bulls remained culturally negative and did not infect any heifer. The 4 infected, nonvaccinated bulls were then vaccinated. Two bulls remained infected 9 weeks after primary vaccination, as determined by the virgin heifer test and cultural examination of preputial washings. Serologic data from 7 sampling periods were different (P less than 0.001) for vaccinated vs nonvaccinated bulls at 4 (against K antigen) or 6 (against O antigen) weeks after primary vaccination. Vaccination was effective in eliminating the infection in most of the infected bulls, but cannot be recommended as the sole measure of control in infected herds.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000941:Antigens / Q000276:immunology; D000942:Antigens, Bacterial / Q000276:immunology; D000954:Antigens, Surface; D001428:Bacterial Vaccines / Q000276:immunology*; D002169:Campylobacter Infections / Q000628:therapy / Q000662:veterinary*; D002168:Campylobacter fetus / Q000276:immunology*; D002417:Cattle; D002418:Cattle Diseases / Q000628:therapy*; D005260:Female; D005832:Genital Diseases, Male / Q000628:therapy / Q000662:veterinary*; D008297:Male; D019081:O Antigens; D014611:Vaccination / Q000662:veterinary*
D000907:Antibodies, Bacterial; D000941:Antigens; D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001428:Bacterial Vaccines; C030659:K antigens; D019081:O Antigens